Patent · US Expired

Organoprotective solutions

US6313104A · kind A · utility

0Cited by

13References

8Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

F. J. van der Woude
Benito Yard · Freinsheim, DE
Dieter Herr · Altrip, DE
Volker Laux · Mainz, DE

Key dates

Filing date	Jan 22, 1999
Grant date	Nov 6, 2001
Priority date	—
Expiry date	Jan 22, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA01N1/126
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of polysulfated glycosaminoglycans having a sulfur content of at least 12.5% for producing pharmaceutical preparations for inhibiting the .gamma.-interferon-induced upregulation of the MHC Class I and MHC Class II proteins and ICAM-1. The invention furthermore relates to organoprotective solutions comprising polysulfated glycosaminoglycans and to a process for the ex-vivo protection of transplant organs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.